DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Second, all dystrophinopathy patients in our database with out-of-frame or truncating variants, and preserved ambulation beyond the age of 16 years, had available dystrophin quantification assays on muscle biopsy tissue; otherwise, we would have risked excluding BMD patients with truncating variants and preservation of ambulation into adult age.